Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-218.85%
operating margin TTM
-178.06%
revenue TTM
62.67 Million
revenue per share TTM
0.49$
valuation ratios | |
|---|---|
| pe ratio | -3.77 |
| peg ratio | 0.00 |
| price to book ratio | 0.54 |
| price to sales ratio | 432.50 |
| enterprise value multiple | -256.57 |
| price fair value | 0.54 |
profitability ratios | |
|---|---|
| gross profit margin | 22.63% |
| operating profit margin | -178.06% |
| pretax profit margin | -218.85% |
| net profit margin | -218.85% |
| return on assets | -11.01% |
| return on equity | -17.55% |
| return on capital employed | -11.58% |
liquidity ratios | |
|---|---|
| current ratio | 4.37 |
| quick ratio | 4.24 |
| cash ratio | 3.55 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 267.26 |
| operating cycle | 1,055.90 |
| days of payables outstanding | 188.76 |
| cash conversion cycle | 867.14 |
| receivables turnover | 0.46 |
| payables turnover | 1.93 |
| inventory turnover | 1.37 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.06 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.06 |
| interest coverage | -4.24 |
| cash flow to debt ratio | -1.39 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.68 |
| cash per share | 8.67 |
| operating cash flow per share | -0.68 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.39 |
| short term coverage ratios | -1.70 |
| capital expenditure coverage ratio | -823.49 |
Frequently Asked Questions
When was the last time China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) reported earnings?
China SXT Pharmaceuticals, Inc. (SXTC) published its most recent earnings results on 31-07-2025.
What is China SXT Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC)'s trailing twelve months ROE is -17.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. China SXT Pharmaceuticals, Inc. (SXTC) currently has a ROA of -11.01%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SXTC's net profit margin stand at?
SXTC reported a profit margin of -218.85% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SXTC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.37 in the most recent quarter. The quick ratio stood at 4.24, with a Debt/Eq ratio of 0.06.